Aaron Davidson

Aaron Davidson

Director/Board Member at PERIMETER MEDICAL IMAGING AI, INC.

Net worth: 46 514 $ as of 31/08/2026

57 year
Health Technology
Finance
Consumer Services

Profile

Aaron Davidson is the founder of Cronometer Software, Inc., founded in 2005, serving as Chief Executive Officer.
Current jobs include Chairman at Conavi Medical, Inc.; Director at Cardeas Pharma Corp., Tranzyme Pharma, Inc. (Canada), Motra Inc., and Conavi Medical Corp.; Managing Director at H.I.G.
BioHealth Partners LLC since 2004; and Independent Director at Perimeter Medical Imaging AI, Inc. since 2020.
Former jobs include Director at Salmedix, Inc. (2004–2006), HyperBranch Medical Technology, Inc. (2006–2018), Novadaq Technologies, Inc. (2004–2015), ForSight VISION5, Inc. (2014–2016), Lundbeck Seattle BioPharmaceuticals, Inc. (2006–2014), and other companies including Intact Vascular, Inc., Gemin X Pharmaceuticals US, Inc., OncoGenex Pharmaceuticals, Inc., Nutrinia Ltd., On Target Laboratories, Inc., Titan Medical, Inc.; Managing Director at H.I.G.
Capital LLC (2004–2018); Principal at Eli Lilly & Co.; Vice President at Ventures West Management, Inc.; CFO & Senior VP-Corporate Development at Profound Medical, Inc.; and Senior Vice President-Corporate Development at Profound Medical Corp.
(2021–2022).
Education includes undergraduate studies at McGill University and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/11/2025 164,000 ( 0.11% ) 33 620 $ 31/08/2026
0.1%
17/02/2026 106,561 ( 0.1% ) 12 894 $ 31/08/2026

Aaron Davidson active positions

CompaniesPositionStart
PERIMETER MEDICAL IMAGING AI, INC. Director/Board Member 26/08/2020
Director/Board Member 01/01/2021
Chief Executive Officer 01/01/2005
Chairman -
Director/Board Member -
Private Equity Investor 01/01/2004
Tranzyme Pharma, Inc. (Canada)
Director/Board Member -

Former positions of Aaron Davidson

CompaniesPositionEnd
PROFOUND MEDICAL CORP. Director of Finance/CFO 19/05/2021
Corporate Officer/Principal 01/05/2018
░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Aaron Davidson's experience

Training of Aaron Davidson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Tranzyme Pharma, Inc. (Canada)

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Aaron Davidson
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!